These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
446 related articles for article (PubMed ID: 22321904)
1. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). Knoebl P; Marco P; Baudo F; Collins P; Huth-Kühne A; Nemes L; Pellegrini F; Tengborn L; Lévesque H; J Thromb Haemost; 2012 Apr; 10(4):622-31. PubMed ID: 22321904 [TBL] [Abstract][Full Text] [Related]
2. Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry. Tengborn L; Baudo F; Huth-Kühne A; Knoebl P; Lévesque H; Marco P; Pellegrini F; Nemes L; Collins P; BJOG; 2012 Nov; 119(12):1529-37. PubMed ID: 22901076 [TBL] [Abstract][Full Text] [Related]
3. Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry. Baudo F; Collins P; Huth-Kühne A; Lévesque H; Marco P; Nemes L; Pellegrini F; Tengborn L; Knoebl P; Blood; 2012 Jul; 120(1):39-46. PubMed ID: 22618709 [TBL] [Abstract][Full Text] [Related]
4. Identifying risk factors and optimizing standard of care for patients with acquired haemophilia A: Results from a Czech patient cohort. Salaj P; Geierová V; Ivanová E; Loužil J; Pohlreichová V; Hrachovinová I; Dulíček P Haemophilia; 2020 Jul; 26(4):643-651. PubMed ID: 32590889 [TBL] [Abstract][Full Text] [Related]
5. Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). Collins P; Baudo F; Knoebl P; Lévesque H; Nemes L; Pellegrini F; Marco P; Tengborn L; Huth-Kühne A; Blood; 2012 Jul; 120(1):47-55. PubMed ID: 22517903 [TBL] [Abstract][Full Text] [Related]
6. Outcome of CARE: a 6-year national registry of acquired haemophilia A in China. Sun B; Xue F; Feng Y; Sun J; Yu Z; Hou M; Zhang J; Zeng X; Zhao Y; Lian S; Huang M; Niu T; Cui Z; Wu J; Yang R Br J Haematol; 2019 Dec; 187(5):653-665. PubMed ID: 31372978 [TBL] [Abstract][Full Text] [Related]
7. Long term outcome of patients with acquired haemophilia--a monocentre interim analysis of 82 patients. Zeitler H; Goldmann G; Marquardt N; Ulrich-Merzenich G Atheroscler Suppl; 2013 Jan; 14(1):223-8. PubMed ID: 23357169 [TBL] [Abstract][Full Text] [Related]
8. Outcome of acquired haemophilia in France: the prospective SACHA (Surveillance des Auto antiCorps au cours de l'Hémophilie Acquise) registry. Borg JY; Guillet B; Le Cam-Duchez V; Goudemand J; Lévesque H; Haemophilia; 2013 Jul; 19(4):564-70. PubMed ID: 23574453 [TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and outcomes of acquired hemophilia A: experience at a single center in Japan. Ogawa Y; Yanagisawa K; Uchiumi H; Ishizaki T; Mitsui T; Gouda F; Ieko M; Ichinose A; Nojima Y; Handa H Int J Hematol; 2017 Jul; 106(1):82-89. PubMed ID: 28299631 [TBL] [Abstract][Full Text] [Related]
10. FEIBA in the treatment of acquired haemophilia A: results from the prospective multicentre French 'FEIBA dans l'hémophilie A acquise' (FEIBHAC) registry. Borg JY; Négrier C; Durieu I; Dolimier E; Masquelier AM; Lévesque H; Haemophilia; 2015 May; 21(3):330-337. PubMed ID: 25359571 [TBL] [Abstract][Full Text] [Related]
11. Treatment of minor severe acquired haemophilia. Is there a rationale for immunoadsorption? Goldmann G; Marquardt N; Horneff S; Oldenburg J; Zeitler H Atheroscler Suppl; 2015 May; 18():74-9. PubMed ID: 25936308 [TBL] [Abstract][Full Text] [Related]
13. Acquired Haemophilia A in four north European countries: survey of 181 patients. Lindahl R; Nummi V; Lehtinen AE; Szanto T; Hiltunen L; Olsson A; Glenthoej A; Chaireti R; Vaide I; Funding E; Zetterberg E Br J Haematol; 2023 Apr; 201(2):326-333. PubMed ID: 36541135 [TBL] [Abstract][Full Text] [Related]
14. An extra X does not prevent acquired hemophilia - Pregnancy-associated acquired hemophilia A. Barg AA; Livnat T; Kenet G Thromb Res; 2017 Mar; 151 Suppl 1():S82-S85. PubMed ID: 28262242 [TBL] [Abstract][Full Text] [Related]
16. Inhibitor development and mortality in non-severe hemophilia A. Eckhardt CL; Loomans JI; van Velzen AS; Peters M; Mauser-Bunschoten EP; Schwaab R; Mazzucconi MG; Tagliaferri A; Siegmund B; Reitter-Pfoertner SE; van der Bom JG; Fijnvandraat K; J Thromb Haemost; 2015 Jul; 13(7):1217-25. PubMed ID: 25912309 [TBL] [Abstract][Full Text] [Related]
17. Inhibitor eradication and treatment for acquired hemophilia A. Franchini M; Focosi D Expert Rev Hematol; 2024 Jun; 17(6):233-240. PubMed ID: 38708599 [TBL] [Abstract][Full Text] [Related]
18. A low-dose rituximab regimen for first-line treatment of acquired haemophilia A. Hunt S; Robertson J; Conn J; Casey J; Royle J; Collins J; Hourigan M; Richmond J; Yang Wang T; Mills A; Mason J Eur J Haematol; 2022 Jan; 108(1):28-33. PubMed ID: 34528303 [TBL] [Abstract][Full Text] [Related]
19. Acquired hemophilia A: a review of recent data and new therapeutic options. Franchini M; Vaglio S; Marano G; Mengoli C; Gentili S; Pupella S; Liumbruno GM Hematology; 2017 Oct; 22(9):514-520. PubMed ID: 28441921 [TBL] [Abstract][Full Text] [Related]
20. Prevention and Management of Bleeding Episodes in Patients with Acquired Hemophilia A. Knöbl P Drugs; 2018 Dec; 78(18):1861-1872. PubMed ID: 30542801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]